期刊文献+

162例丙型肝炎患者远期转归研究 被引量:2

Longterm Outcomes of 162 Cases Involving Hepatitis C
下载PDF
导出
摘要 目的观察162例不同临床感染类型丙型肝炎(HC)患者16年后的转归情况。方法将162例HC患者按急性期症状分组,采集5ml静脉血,检测丙型肝炎病毒(HCV)抗体、RNA、丙氨酸氨基转移酶(ALT)、透明质酸(HA)、Ⅲ型前胶原肽(PCⅢ)和Ⅳ型胶原(ⅣC)。结果本次调查的162例患者中抗-HCV阳性率为95.7%,HCVRNA阳性率为77.8%,ALT异常率为20.4%,不同临床类型HC患者抗-HCV、HCVRNA阳性率和ALT异常率间差异无统计学意义(P>0.05)。HA异常率为64.2%,PCⅢ异常率为9.3%,ⅣC异常率为40.1%。HA、PCⅢ和ⅣC3项指标均正常者共28例(18.52%),11例(6.8%)3项指标均处于肝硬化临界值。经性别分层分析,女性感染年龄≥40岁者抗体较易阴转(P=0.004)。结论不同临床型HC患者16年后的转归无差异,个体转归差异与性别和初始感染年龄有关。 Objective To observe the long outcomes of 162 cases involving hepatitis C with different infection type for 16 years. Methods 162 cases were divided into different groups according to their symptoms at acute stage. Five milliliter of blood were taken from each patient and the serum level of ALT, HCV - RNA, Anti - HCV, hyaluronic acid (HA), Ⅲ precollagen (PCIU), Ⅳ collagen (IVC) were tested. Results 95.7% of 162 cases showed positive anti - HCV, 77.8% of them showed positive HCV - RNA. The abnormal rate of ALT was 20. 4%. The rates of positive anti - HCV, positive HCV - RNA and the abnormal ALT were no significant differences among the different kinds of hepatitis C ( P 〉 0. 05). The abnormal rates of HA, PCIU and IVC were 64. 2% , 9. 3% and 40. 1% respectively. 28 ( 18.5% ) out of 162 cases presented normal value on the three indexes and 11 (6. 8% ) cases were abnormal. Stratified analysis showed that anti - HCV in serum was easier to be changed to negative in female of infection age over 40 years old than other patients ( P = 0. 004). Conclusion There was no significant differences in the 16 - year outcomes among different kinds of hepatitis C. The individual outcome was related to the sex and the initial infection age.
出处 《中国全科医学》 CAS CSCD 2007年第4期275-276,278,共3页 Chinese General Practice
基金 河北省卫生厅科研立项课题(05360)
关键词 肝炎 丙型 慢性 谷丙转氨酶 抗体 丙型 肝炎病毒 Hepatitis C, chronic ALT Anti-HCV Hepatitis virus
  • 相关文献

参考文献10

  • 1Alberti A,Benvegue L.Management of hepatitis C[J].J Hepatol,2003,38:104-118.
  • 2Di Bisceglie AM,Goodman ZD,Ishak KG,et al.Long-term clinical and histopathological follow up of chronic post-transfusion hepatitis[J].Hepatology,1991,14:969-974.
  • 3Poynard T,Bedossa P,Opolon P.Natural history of liver progression in patients with chronic hepatitis C[J].Lancet,1997,349:825-832.
  • 4孟宗达,孙永德,孙德贵,刘彩云,陈学儒,王素玉,陈中,牛建章,赵玉良,陈淑芬,田茶,陈素良,徐东刚,康铁军,史蕴华.163例丙型肝炎八年前瞻性研究[J].中华内科杂志,1995,34(8):548-552. 被引量:9
  • 5Flamm SL.Chronic Hepatitis C virus infection[J].JAMA,2003,289:2413-2417.
  • 6胡青,高大明,叶军,武聚山,刘德恭.丙型肝炎的诊断治疗现状[J].中国全科医学,2003,6(2):167-168. 被引量:7
  • 7Daze C,Cramp M,Dietze O,et al.The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A,non-B hepatitis in a plasmapheresis centre[J].Gut,1999,44:563-567.
  • 8Cheung RC,Chan RT,Lok AS.Longitudinal study of Hepatitis C viremia in Choronic Hepatitis C[J].J Medical Virol,1993,41:338.
  • 9赵建军,郭芹,兰晓青,管小江.丙型肝炎病毒感染127例临床病理分析[J].中国基层医药,2004,11(12):1505-1505. 被引量:4
  • 10李敏,吴引伟,刘新钰.慢性丙型肝炎患者血清抗-HCV及HCVRNA水平与病情的关系研究[J].中国全科医学,2005,8(16):1313-1314. 被引量:1

二级参考文献9

共引文献17

同被引文献23

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2Pynard T,Ratziu V,Benmanov Y,et al.Fibrosis in patients with chronic hepatitis C:detection and significance[J].Sem Liver Dis,2000,20:47-55.
  • 3Fontaine H,Nalpas B,Poulet B,et al.Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C[J].Hum Pathol,2001,32:904-909.
  • 4Ohmori S,Shiraki K,Sugimoto K,et al.High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases[J].Hum Pathol,2001,32:1363-1370.
  • 5Cheah PL,Looi LM,Nazarina AR,et al.Association of Ki-67 with raised transaminases in hepatocellular carcinoma[J].Malays J Pathol,2008,30(2):103-107.
  • 6Knodell RG,Ishak KG,Black WC,et al.Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis[J].Hepatology,1981,1:431-435.
  • 7El-Assal ON,Yamanoi A,Soda Y,et al.Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver:possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J].Hepatology,1998,27:1554-1562.
  • 8Koukoulis GK.Chronic hepatitis C:grading,staging,and searching for reliable predictors of outcome[J].Hum Pathol,2001,32:899-903.
  • 9Tsoli E,Zacharatos P,Dasiou-Plakida D,et al.Growth index is independent of microvessel density in non-small-cell lung carcinomas[J].Hum Pathol,2002,33:812-818.
  • 10Chosay JG,Fisher MA,Farhood A,et al.Role of PECAM-1(CD31) in neutrophil transmigration in murine models of liver and peritoneal inflammation[J].AJP-Gastrointestinal and Liver Physiology,1998,274:G776-782.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部